National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

phenoxodiol
A synthetic flavonoid derivative. Phenoxodiol activates the mitochondrial caspase system, inhibits X-linked inhibitor of apoptosis (XIAP), and disrupts FLICE inhibitory protein (FLIP) expression, resulting in tumor cell apoptosis. This agent also inhibits DNA topoisomerase II by stabilizing the cleavable complex, thereby preventing DNA replication and resulting in tumor cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:NV-06
Chemical structure name:3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol



Previous:PF-00299804, PGLA/PEG copolymer-based paclitaxel, PHA-739358, Phenergan, phenobarbital
Next:phentolamine mesylate, phosphatidylcholine-bound silybin, phosphorodiamidate morpholino oligomer AVI-4126, phosphorus P32, Photochlor

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov